Impaired pulmonary vascular development in bronchopulmonary dysplasia

Neonatology

Volumn 107, Issue 4, 2015, Pages 344-351

  Baker, Christopher D ^a   Abman, Steven H ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease of infancy; Premature birth; Vascular development

Indexed keywords

RETINOL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; CONFERENCE PAPER; ENDOTHELIAL PROGENITOR CELL; EPIGENETICS; EXPERIMENTAL DISEASE; HUMAN; LUNG DEVELOPMENT; LUNG DYSPLASIA; MEDICAL GENETICS; MESENCHYMAL STROMA CELL; MOUSE MODEL; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PULMONARY VASCULAR DISEASE; VASCULAR DISEASE; VITAMIN SUPPLEMENTATION; ANIMAL; BRONCHOPULMONARY DYSPLASIA; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; LUNG; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NEWBORN; PATHOLOGY; RAT; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MICE; NEOVASCULARIZATION, PATHOLOGIC; RATS;

EID: 84930604012     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000381129     Document Type: Conference Paper

References (121)

1. Northway WH, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
2. Chambers HM, van Velzen D: Ventilator-related pathology in the extremely immature lung. Pathology 1989; 21: 79-83.
3. Hislop AA, Haworth SG: Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 1990; 9: 152-161.
4. Jobe AH: The new BPD: an arrest of lung development. Pediatr Res 1999; 46: 641-643.
5. Hislop AA: Airway and blood vessel interaction during lung development. J Anat 2002; 201: 325-334.
6. Coalson JJ: Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81.
7. Baker CD, Alvira CM: Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration. Curr Opin Pediatr 2014; 26: 306-314.
8. LeBlanc MH, Graves GR, Rawson TW, Moffitt J: Long-term outcome of infants at the margin of viability. J Miss State Med Assoc 1999; 40: 111-114.
9. Patel RM, Kandefer S, Walsh MC, Bell EF, Carlo WA, Laptook AR, Sanchez PJ, Shankaran S, Van Meurs KP, Ball MB, Hale EC, Newman NS, Das A, Higgins RD, Stoll BJ; Eunice Kennedy Shriver NICHD Neonatal Research Network: Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 2015; 372: 331-340.
10. Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, Hale EC, Newman NS, Schibler K, Carlo WA, Kennedy KA, Poindexter BB, Finer NN, Ehrenkranz RA, Duara S, Sanchez PJ, O'Shea TM, Goldberg RN, Van Meurs KP, Faix RG, Phelps DL, Frantz ID 3rd, Watterberg KL, Saha S, Das A, Higgins RD: Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126: 443-456.
11. Ali Z, Schmidt P, Dodd J, Jeppesen DL: Bronchopulmonary dysplasia: A review. Arch Gynecol Obstet 2013; 288: 325-333.
12. Copland I, Post M: Lung development and fetal lung growth. Paediatr Respir Rev 2004; 5(suppl A):S259-S264.
13. Coalson JJ: Pathology of chronic lung disease of early infancy; in Bland RD, Coalson JJ (eds): Chronic Lung Disease in Early Infancy. New York, Dekker, 1999, vol 137, pp 85-124.
14. Husain AN, Siddiqui NH, Stocker JT: Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29: 710-717.
15. Abman SH: Bronchopulmonary dysplasia: A vascular hypothesis'. Am J Respir Crit Care Med 2001; 164: 1755-1756.
16. Mourani PM, Abman SH: Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr Opin Pediatr 2013; 25: 329-337.
17. Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM: Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid-treated mouse lung. Pediatr Res 2000; 47: 606-613.
18. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH: Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000; 279:L600-L607.
19. Thébaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, Archer SL: Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005; 112: 2477-2486.
20. Ding BS, Nolan DJ, Guo P, Babazadeh AO, Cao Z, Rosenwaks Z, Crystal RG, Simons M, Sato TN, Worgall S, Shido K, Rabbany SY, Rafii S: Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 2011; 147: 539-553.
21. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM: Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 164: 1971-1980.
22. Flamme I, Risau W: Induction of vasculogenesis and hematopoiesis in vitro. Development 1992; 116: 435-439.
23. Risau W: Mechanisms of angiogenesis. Nature 1997; 386: 671-674.
24. Groenman F, Unger S, Post M: The molecular basis for abnormal human lung development. Biol Neonate 2005; 87: 164-177.
25. Narayanan M, Owers-Bradley J, Beardsmore CS, Mada M, Ball I, Garipov R, Panesar KS, Kuehni CE, Spycher BD, Williams SE, Silverman M: Alveolarization continues during childhood and adolescence: new evidence from helium-3 magnetic resonance. Am J Respir Crit Care Med 2012; 185: 186-191.
26. Hilgendorff A, Reiss I, Ehrhardt H, Eickelberg O, Alvira CM: Chronic lung disease in the preterm infant. Lessons learned from animal models. Am J Respir Cell Mol Biol 2014; 50: 233-245.
27. Berger J, Bhandari V: Animal models of bronchopulmonary dysplasia. The term mouse models. Am J Physiol Lung Cell Mol Physiol 2014; 307:L936-L947.
28. D'Angio CT, Ryan RM: Animal models of bronchopulmonary dysplasia. The preterm and term rabbit models. Am J Physiol Lung Cell Mol Physiol 2014; 307:L959-L969.
29. O'Reilly M, Thebaud B: Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol 2014; 307:L948-L958.
30. Hellstroem B: The effect of high oxygen concentrations and hypothermia on the lung of the newborn mouse. Acta Paediatr Scand1965; 54: 457-466.
31. Warner BB, Stuart LA, Papes RA, Wispe JR: Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998; 275:L110-L117.
32. Wang H, Jafri A, Martin RJ, Nnanabu J, Farver C, Prakash YS, MacFarlane PM: Severity of neonatal hyperoxia determines structural and functional changes in developing mouse airway. Am J Physiol Lung Cell Mol Physiol 2014; 307:L295-L301.
33. O'Reilly M, Harding R, Sozo F: Altered small airways in aged mice following neonatal exposure to hyperoxic gas. Neonatology 2014; 105: 39-45.
34. Choi CW, Kim BI, Hong JS, Kim EK, Kim HS, Choi JH: Bronchopulmonary dysplasia in a rat model induced by intra-amniotic inflammation and postnatal hyperoxia: morphometric aspects. Pediatr Res 2009; 65: 323-327.
35. Tang J-R, Seedorf GJ, Muehlethaler V, Walker DL, Markham NE, Balasubramaniam V, Abman SH: Moderate postnatal hyperoxia accelerates lung growth and attenuates pulmonary hypertension in infant rats after exposure to intra-amniotic endotoxin. Am J Physiol Lung Cell Mol Physiol 2010; 299:L735-L748.
36. Huang LT, Chou HC, Lin CM, Yeh TF, Chen CM: Maternal nicotine exposure exacerbates neonatal hyperoxia-induced lung fibrosis in rats. Neonatology 2014; 106: 94-101.
37. Gortner L, Hilgendorff A, Bahner T, Ebsen M, Reiss I, Rudloff S: Hypoxia-induced intrauterine growth retardation: effects on pulmonary development and surfactant protein transcription. Biol Neonate 2005; 88: 129-135.
38. Monz D, Tutdibi E, Mildau C, Shen J, Kasoha M, Laschke MW, Roolfs T, Schmiedl A, Tschernig T, Bieback K, Gortner L: Human umbilical cord blood mononuclear cells in a double-hit model of bronchopulmonary dysplasia in neonatal mice. PLoS One 2013; 8:e74740.
39. Ratner V, Slinko S, Utkina-Sosunova I, Starkov A, Polin RA, Ten VS: Hypoxic stress exacerbates hyperoxia-induced lung injury in a neonatal mouse model of bronchopulmonary dysplasia. Neonatology 2009; 95: 299-305.
40. Bland RD, Albertine KH, Carlton DP, Mac-Ritchie AJ: Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med 2005; 172: 899-906.
41. Lin Y-J, Markham NE, Balasubramaniam V, Tang J-R, Maxey A, Kinsella JP, Abman SH: Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 2005; 58: 22-29.
42. Tang J-R, Markham NE, Lin Y-J, McMurtry IF, Maxey A, Kinsella JP, Abman SH: Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 2004; 287:L344-L351.
43. Bland RD, Albertine KH, Carlton DP, Kullama L, Davis P, Cho SC, Kim BI, Dahl M, Tabatabaei N: Chronic lung injury in preterm lambs: abnormalities of the pulmonary circulation and lung fluid balance. Pediatr Res 2000; 48: 64-74.
44. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH: Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 2002; 283:L555-L562.
45. Kunig AM, Balasubramaniam V, Markham NE, Morgan D, Montgomery G, Grover TR, Abman SH: Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats. Am J Physiol Lung Cell Mol Physiol 2005; 289:L529-L535.
46. Kendall RL, Thomas KA: Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90: 10705-10709.
47. Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH: Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012; 302:L36-L46.
48. Foidart JM, Schaaps JP, Chantraine F, Munaut C, Lorquet S: Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia- A step forward but not the definitive answer. J Reprod Immunol 2009; 82: 106-111.
49. Hansen AR, Barnés CM, Folkman J, McElrath TF: Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156: 532-536.
50. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, Group CS: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
51. Hasan J, Beharry KD, Valencia AM, Strauss A, Modanlou HD: Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/ chronic lung disease. Pediatrics 2009; 123: 1541-1547.
52. Voller SB, Chock S, Ernst LM, Su E, Liu X, Farrow KN, Mestan KK: Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: A preterm birth cohort study. Early Hum Dev 2014; 90: 195-200.
53. Rozance PJ, Seedorf GJ, Brown A, Roe G, O'Meara MC, Gien J, Tang JR, Abman SH: Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011; 301:L860-L871.
54. Soudee S, Vuillemin L, Alberti C, Mohamed D, Becquet O, Farnoux C, Biran V, Baud O: Fetal growth restriction is worse than extreme prematurity for the developing lung. Neonatology 2014; 106: 304-310.
55. Baker CD, Abman SH, Mourani PM: Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Pediatr Allergy Immunol Pulmonol 2014; 27: 8-16.
56. Gien J, Tseng N, Seedorf G, Roe G, Abman SH: Endothelin-1 impairs angiogenesis in vitro through Rho-kinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res 2013; 73: 252-262.
57. Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J: Endothelin-1 decreases endothelial PPAR? signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2014; 306:L361-L371.
58. Morales E, Sakurai R, Husain S, Paek D, Gong M, Ibe B, Li Y, Husain M, Torday JS, Rehan VK: Nebulized PPAR? agonists: A novel approach to augment neonatal lung maturation and injury repair in rats. Pediatr Res 2014; 75: 631-640.
59. Kim DH, Kim HS: Serial changes of serum endostatin and angiopoietin-1 levels in preterm infants with severe bronchopulmonary dysplasia and subsequent pulmonary artery hypertension. Neonatology 2014; 106: 55-61.
60. Balasubramaniam V: Inhaled nitric oxide reverses hypoxia induced lung hypoplasia in endothelial nitric oxide synthase-deficient mice. Chest 2005; 128: 613S-614S.
61. Galambos C, Sims-Lucas S, Abman SH: Histologic evidence of intrapulmonary anastomoses by three-dimensional reconstruction in severe bronchopulmonary dysplasia. Ann Am Thorac Soc 2013; 10: 475-481.
62. Galambos C, Sims-Lucas S, Abman SH: Threedimensional reconstruction identifies misaligned pulmonary veins as intrapulmonary shunt vessels in alveolar capillary dysplasia. J Pediatr 2014; 164: 192-195.
63. Bhandari V, Bizzarro MJ, Shetty A, Zhong X, Page GP, Zhang H, Ment LR, Gruen JR: Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 2006; 117: 1901-1906.
64. Lavoie PM, Pham C, Jang KL: Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008; 122: 479-485.
65. Hadchouel A, Durrmeyer X, Bouzigon E, Incitti R, Huusko J, Jarreau PH, Lenclen R, Demenais F, Franco-Montoya ML, Layouni I, Patkai J, Bourbon J, Hallman M, Danan C, Delacourt C: Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia. Am J Respir Crit Care Med 2011; 184: 1164-1170.
66. Ambalavanan N, Cotten CM, Page GP, Carlo WA, Murray JC, Bhattacharya S, Mariani TJ, Cuna AC, Faye-Petersen OM, Kelly D, Higgins RD; Genomics, Cytokine Subcommittees of the Eunice Kennedy Shriver NICHD Neonatal Research Network: Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr 2015; 166: 531-537.
67. Wang H, St Julien KR, Stevenson DK, Hoffmann TJ, Witte JS, Lazzeroni LC, Krasnow MA, Quaintance CC, Oehlert JW, Jelliffe-Pawlowski LL, Gould JB, Shaw GM, O'Brodovich HM: A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics 2013; 132: 290-297.
68. Koroglu OA, Onay H, Cakmak B, Bilgin B, Yalaz M, Tunc S, Ozkinay F, Kultursay N: Association of vitamin D receptor gene polymorphisms and bronchopulmonary dysplasia. Pediatr Res 2014; 76: 171-176.
69. Mandell E, Seedorf G, Gien J, Abman SH: Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014; 306:L420-L428.
70. Albertine KH: Progress in understanding the pathogenesis of BPD using the baboon and sheep models. Semin Perinatol 2013; 37: 60-68.
71. Chetty A, Andersson S, Lassus P, Nielsen HC: Insulin-like growth factor-1 (IGF-1) and IGF-receptor (IGF-1r) expression in human lung in RDS and BPD. Pediatr Pulmonol 2004; 37: 128-136.
72. Joss-Moore LA, Metcalfe DB, Albertine KH, McKnight RA, Lane RH: Epigenetics and fetal adaptation to perinatal events: diversity through fidelity. J Animal Sci 2010; 88:E216-E222.
73. Londhe VA, Sundar IK, Lopez B, Maisonet TM, Yu Y, Aghai ZH, Rahman I: Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung. Pediatr Res 2011; 69: 371-377.
74. Kuljaca S, Liu T, Dwarte T, Kavallaris M, Haber M, Norris MD, Martin-Caballero J, Marshall GM: The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells. Carcinogenesis 2009; 30: 1865-1871.
75. Cuna A, Halloran B, Faye-Petersen O, Kelly D, Crossman DK, Cui X, Pandit K, Kaminski N, Bhattacharya S, Ahmad A, Mariani TJ, Ambalavanan N: Alterations in gene expression and DNA methylation during murine and human lung alveolar septation. Am J Respir Cell Mol Biol 2014, Epub ahead of print.
76. Wu YT, Chen WJ, Hsieh WS, Tsao PN, Yu SL, Lai CY, Lee WC, Jeng SF: MicroRNA expression aberration associated with bronchopulmonary dysplasia in preterm infants: A preliminary study. Respir Care 2013; 58: 1527-1535.
77. Yang Y, Qiu J, Kan Q, Zhou XG, Zhou XY: MicroRNA expression profiling studies on bronchopulmonary dysplasia: A systematic review and meta-analysis. Genet Mol Res 2013; 12: 5195-5206.
78. Narasaraju T, Shukla D, More S, Huang C, Zhang L, Xiao X, Liu L: Role of microRNA-150 and glycoprotein nonmetastatic melanoma protein B in angiogenesis during hyperoxiainduced neonatal lung injury. Am J Respir Cell Mol Biol 2015; 52: 253-261.
79. De Paepe ME, Greco D, Mao Q: Angiogenesisrelated gene expression profiling in ventilated preterm human lungs. Exp Lung Res 2010; 36: 399-410.
80. De Paepe ME, Patel C, Tsai A, Gundavarapu S, Mao Q: Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants. Am J Respir Crit Care Med 2008; 178: 180-187.
81. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
82. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, Yoder MC: Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 2005; 105: 2783-2786.
83. Baker CD, Balasubramaniam V, Mourani PM, Sontag MK, Black CP, Ryan SL, Abman SH: Cord blood angiogenic progenitor cells are decreased in bronchopulmonary dysplasia. Eur Respir J 2012; 40: 1516-1522.
84. Borghesi A, Massa M, Campanelli R, Bollani L, Tzialla C, Figar TA, Ferrari G, Bonetti E, Chiesa G, De Silvestri A, Spinillo A, Rosti V, Stronati M: Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2009; 180: 540-546.
85. Estes ML, Mund JA, Ingram DA, Case J: Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr Protoc Cytom 2010; 9(unit 9. 33):1-11.
86. Baker CD, Ryan SL, Ingram DA, Seedorf GJ, Abman SH, Balasubramaniam V: Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med 2009; 180: 454-461.
87. Borghesi A, Massa M, Campanelli R, Garofoli F, Longo S, Cabano R, Mazzucchelli I, Tzialla C, Gavilanes AW, Gazzolo D, Manzoni P, Bollani L, Spinillo A, Rosti V, Stronati M: Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants. Int J Immunopathol Pharmacol 2013; 26: 809-816.
88. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA: Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007; 35: 1109-1118.
89. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, Mortell K, Pollok K, Ferkowicz MJ, Gilley D, Yoder MC: Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004; 104: 2752-2760.
90. Ingram DA, Krier TR, Mead LE, Mcguire C, Prater DN, Bhavsar J, Saadatzadeh MR, Bijangi-Vishehsaraei K, Li F, Yoder MC, Haneline LS: Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 2007; 25: 297-304.
91. Fujinaga H, Baker CD, Ryan SL, Markham NE, Seedorf GJ, Balasubramaniam V, Abman SH: Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants. Am J Physiol Lung Cell Mol Physiol 2009; 297:L1160-L1169.
92. Munoz-Hernandez R, Miranda ML, Stiefel P, Lin RZ, Praena-Fernandez JM, Dominguez-Simeon MJ, Villar J, Moreno-Luna R, Melero-Martin JM: Decreased level of cord blood circulating endothelial colony-forming cells in preeclampsia. Hypertension 2014; 64: 165-171.
93. von Versen-Hoynck F, Brodowski L, Dechend R, Myerski AC, Hubel CA: Vitamin D antagonizes negative effects of preeclampsia on fetal endothelial colony forming cell number and function. PLoS One 2014; 9:e98990.
94. Mestan KK, Check J, Minturn L, Yallapragada S, Farrow KN, Liu X, Su E, Porta N, Gotteiner N, Ernst LM: Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension. Placenta 2014; 35: 570-574.
95. Ohle SJ, Anandaiah A, Fabian AJ, Fine A, Kotton DN: Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells. Am J Respir Cell Mol Biol 2012; 47: 11-19.
96. Baker CD, Seedorf GJ, Wisniewski BL, Black CP, Ryan SL, Balasubramaniam V, Abman SH: Endothelial colony-forming cell conditioned media promote angiogenesis in vitro and prevent pulmonary hypertension in experimental bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2013; 305:L73-L81.
97. Prockop DJ: Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
98. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
99. Erices A, Conget P, Minguell JJ: Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235-242.
100. Baksh D, Yao R, Tuan RS: Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007; 25: 1384-1392.
101. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22: 1330-1337.
102. Pierro M, Thebaud B: Mesenchymal stem cells in chronic lung disease: culprit or savior? Am J Physiol Lung Cell Mol Physiol 2010; 298:L732-L734.
103. Popova AP, Bozyk PD, Bentley JK, Linn MJ, Goldsmith AM, Schumacher RE, Weiner GM, Filbrun AG, Hershenson MB: Isolation of tracheal aspirate mesenchymal stromal cells predicts bronchopulmonary dysplasia. Pediatrics 2010; 126:e1127-e1133.
104. Popova AP, Bozyk PD, Goldsmith AM, Linn MJ, Lei J, Bentley JK, Hershenson MB: Autocrine production of TGF-1 promotes myofibroblastic differentiation of neonatal lung mesenchymal stem cells. Am J Physiol Lung Cell Mol Physiol 2010; 298:L735-L743.
105. Popova AP, Bentley JK, Cui TX, Richardson MN, Linn MJ, Lei J, Chen Q, Goldsmith AM, Pryhuber GS, Hershenson MB: Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2014; 307:L231-L239.
106. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH: Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 354-364.
107. Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D, Hascoet JM, Hibbs AM, Kinsella JP, Mercier JC, Rich W, Schreiber MD, Wongsiridej PS, Subhedar NV, Van Meurs KP, Voysey M, Barrington K, Ehrenkranz RA, Finer NN; Meta-analysis of Preterm Patients on Inhaled Nitric Oxide Collaboration: Inhaled nitric oxide in preterm infants: an individual-patient data metaanalysis of randomized trials. Pediatrics 2011; 128: 729-739.
108. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE; NO CLD Group: Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006; 355: 343-353.
109. Kinsella JP, Cutter GR, Steinhorn RH, Nelin LD, Walsh WF, Finer NN, Abman SH: Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns. J Pediatr 2014; 165: 1104-1108.
110. Gadhia MM, Cutter GR, Abman SH, Kinsella JP: Effects of early inhaled nitric oxide therapy and vitamin a supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr 2014; 164: 744-748.
111. Meyer S, Gortner L, NeoVita ATI: Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants. Neonatology 2014; 105: 182-188.
112. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S: Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 2009; 180: 1122-1130.
113. Ionescu L, Byrne RN, van Haaften T, Vadivel A, Alphonse RS, Rey-Parra GJ, Weissmann G, Hall A, Eaton F, Thebaud B: Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol 2012; 303:L967-L977.
114. Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G, Emery D, Bodiga S, Eaton F, Peault B, Mosca F, Lazzari L, Thebaud B: Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 2013; 68: 475-484.
115. Van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J, Haromy A, Eaton F, Chen M, Hashimoto K, Abley D, Korbutt G, Archer SL, Thebaud B: Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 2009: 180: 1131-1142.
116. Alphonse RS, Vadivel A, Fung M, Shelley WC, Critser PJ, Ionescu L, O'Reilly M, Ohls RK, McConaghy S, Eaton F, Zhong S, Yoder M, Thebaud B: Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth. Circulation 2014; 129: 2144-2157.
117. Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, Park WS: Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 doseescalation clinical trial. J Pediatr 2014; 164: 966-972.
118. Baker CD, Abman SH: Umbilical cord stem cell therapy for bronchopulmonary dysplasia: ready for prime time? Thorax 2013; 68: 402-404.
119. Kourembanas S: Stem cell-based therapy for newborn lung and brain injury: feasible, safe, and the next therapeutic breakthrough? J Pediatr 2014; 164: 954-956.
120. McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL: Bronchopulmonary dysplasia: NHLBI workshop on the primary prevention of chronic lung diseases. Ann Am Thorac Soc 2014; 11(suppl 3):S146-S153.
121. Cuevas Guaman M, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM: Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol 2015, DOI:10. 1055/s-0035-1547326.